{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T21:57:20Z","timestamp":1790546240659,"version":"4.1.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"23","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T00:00:00Z","timestamp":1731456000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001412","name":"Council of Scientific and Industrial Research, India","doi-asserted-by":"publisher","award":["CSIR-37(1722)\/19\/EMR-II"],"award-info":[{"award-number":["CSIR-37(1722)\/19\/EMR-II"]}],"id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009589","name":"Jadavpur University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009589","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009104","name":"Department of Health Research, India","doi-asserted-by":"publisher","award":["11013_33_2021-GIA HR"],"award-info":[{"award-number":["11013_33_2021-GIA HR"]}],"id":[{"id":"10.13039\/501100009104","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.heliyon.2024.e40404","type":"journal-article","created":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T16:26:24Z","timestamp":1731687984000},"page":"e40404","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Exploring the key structural attributes and chemico-biological interactions of pyridinone-based SARS-CoV-2 3CLpro inhibitors through validated structure-based drug design strategies"],"prefix":"10.1016","volume":"10","author":[{"given":"Suvankar","family":"Banerjee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandip Kumar","family":"Baidya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balaram","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarun","family":"Jha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5523-7716","authenticated-orcid":false,"given":"Nilanjan","family":"Adhikari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2024.e40404_bib1","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ijsu.2020.04.018","article-title":"The socio-economic implications of the coronavirus pandemic (COVID-19): a review","volume":"78","author":"Nicola","year":"2020","journal-title":"Int. J. Surg."},{"key":"10.1016\/j.heliyon.2024.e40404_bib2","first-page":"1","article-title":"Positive and negative impacts of COVID-19, an analysis with special reference to challenges on the supply chain in South Asian countries","volume":"23","author":"Karunathilake","year":"2020","journal-title":"J. Econ. Soc. Dev."},{"key":"10.1016\/j.heliyon.2024.e40404_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2021.e07307","article-title":"COVID-19: socio-economic impacts and challenges in the working group","volume":"7","author":"Mulugeta","year":"2021","journal-title":"Heliyon"},{"key":"10.1016\/j.heliyon.2024.e40404_bib4","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1016\/j.chest.2020.07.061","article-title":"SARS CoV-2 Detection from upper and lower respiratory tract specimens: diagnostic and infection control implications","volume":"158","author":"Murphy","year":"2020","journal-title":"Chest"},{"key":"10.1016\/j.heliyon.2024.e40404_bib5","unstructured":"https:\/\/www.worldometers.info\/coronavirus\/, as accessed in December 2022."},{"key":"10.1016\/j.heliyon.2024.e40404_bib6","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s42003-020-01577-x","article-title":"Identification of 3-chymotrypsin like protease (3CLPro) inhibitors as potential anti-SARS-CoV-2 agents","volume":"4","author":"Mody","year":"2021","journal-title":"Commun. Biol."},{"key":"10.1016\/j.heliyon.2024.e40404_bib7","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41586-020-2008-3","article-title":"A new coronavirus associated with human respiratory disease in China","volume":"579","author":"Wu","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.heliyon.2024.e40404_bib8","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jpha.2020.03.009","article-title":"Structural basis of SARS-CoV-2 3CLpro and anti-COVID-19 drug discovery from medicinal plants","volume":"10","author":"Tahir Ul Qamar","year":"2020","journal-title":"J. Pharm. Anal."},{"key":"10.1016\/j.heliyon.2024.e40404_bib9","first-page":"473","article-title":"Robust classification-based molecular modelling of diverse chemical entities as potential SARS-CoV-2 3CLpro inhibitors: theoretical justification in light of experimental evidences, SAR QSAR Env","volume":"32","author":"Adhikari","year":"2021","journal-title":"Res."},{"key":"10.1016\/j.heliyon.2024.e40404_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2020.e04743","article-title":"Molecular biology of coronaviruses: current knowledge","volume":"6","author":"Artika","year":"2020","journal-title":"Heliyon"},{"key":"10.1016\/j.heliyon.2024.e40404_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2022.134642","article-title":"Glycyrrhizin as a promising kryptonite against SARS-CoV-2: clinical, experimental, and theoretical evidences","volume":"1275","author":"Banerjee","year":"2023","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.heliyon.2024.e40404_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2021.692168","article-title":"Catalytic dyad residues His41 and Cys145 impact the catalytic activity and overall conformational fold of the main SARS-CoV-2 protease 3-chymotrypsin-like protease","volume":"9","author":"Ferreira","year":"2021","journal-title":"Front. Chem."},{"key":"10.1016\/j.heliyon.2024.e40404_bib13","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1007\/s11030-021-10259-7","article-title":"New insights into the catalytic mechanism of the SARS-CoV-2 main protease: an ONIOM QM\/MM approach","volume":"26","author":"Fernandes","year":"2022","journal-title":"Mol. Divers."},{"key":"10.1016\/j.heliyon.2024.e40404_bib14","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/s41422-020-0356-z","article-title":"Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease","volume":"30","author":"Ma","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.heliyon.2024.e40404_bib15","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1007\/s11030-020-10166-3","article-title":"First structure\u2013activity relationship analysis of SARS-CoV-2 virus main protease (Mpro) inhibitors: an endeavor on COVID-19 drug discovery","volume":"25","author":"Amin","year":"2021","journal-title":"Mol. Divers."},{"key":"10.1016\/j.heliyon.2024.e40404_bib16","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","article-title":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro","volume":"30","author":"Wang","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.heliyon.2024.e40404_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.173977","article-title":"Brief review on repurposed drugs and vaccines for possible treatment of COVID-19","volume":"898","author":"De","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.heliyon.2024.e40404_bib18","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/d41587-020-00003-1","article-title":"Coronavirus puts drug repurposing on the fast track","volume":"38","author":"Harrison","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.heliyon.2024.e40404_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.704205","article-title":"The drug repurposing for COVID-19 clinical trials provide very effective therapeutic combinations: lessons learned from major clinical studies","volume":"12","author":"Chakraborty","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.heliyon.2024.e40404_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.metop.2021.100121","article-title":"Drug repurposing in COVID-19: a review with past, present and future","volume":"12","author":"Srivastava","year":"2021","journal-title":"Metabol. Open"},{"key":"10.1016\/j.heliyon.2024.e40404_bib21","doi-asserted-by":"crossref","DOI":"10.1177\/1753466620951053","article-title":"Doxycycline treatment of high-risk COVID-19-positive patients with comorbid pulmonary disease","volume":"14","author":"Yates","year":"2020","journal-title":"Ther. Adv. Respir. Dis."},{"key":"10.1016\/j.heliyon.2024.e40404_bib22","doi-asserted-by":"crossref","first-page":"D668","DOI":"10.1093\/nar\/gkj067","article-title":"DrugBank: a comprehensive resource for in silico drug discovery and exploration","volume":"34","author":"Wishart","year":"2006","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.heliyon.2024.e40404_bib23","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1021\/acsmedchemlett.1c00326","article-title":"Optimization of triarylpyridinone inhibitors of the main protease of SARS-CoV-2 to low-nanomolar antiviral potency","volume":"12","author":"Zhang","year":"2021","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.heliyon.2024.e40404_bib24","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.str.2021.06.002","article-title":"Structure-guided design of a perampanel-derived pharmacophore targeting the SARS-CoV-2 main protease","volume":"29","author":"Deshmukh","year":"2021","journal-title":"Structure"},{"key":"10.1016\/j.heliyon.2024.e40404_bib25","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1021\/acscentsci.1c00039","article-title":"Potent noncovalent inhibitors of the main protease of SARS-COV-2 from molecular sculpting of the drug perampanel guided by free energy perturbation calculations","volume":"7","author":"Zhang","year":"2021","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.heliyon.2024.e40404_bib26","series-title":"ChemDraw Ultra 5.0","year":"2010"},{"key":"10.1016\/j.heliyon.2024.e40404_bib27","series-title":"Discovery Studio 3.0 (DS 3.0)","year":"2015"},{"key":"10.1016\/j.heliyon.2024.e40404_bib28","doi-asserted-by":"crossref","first-page":"11591","DOI":"10.1039\/D2NJ01923J","article-title":"The first report on predictive comparative ligand-based multi-QSAR modeling analysis of 4-pyrimidinone and 2-pyridinone based APJ inhibitors","volume":"46","author":"Banerjee","year":"2022","journal-title":"New J. Chem."},{"key":"10.1016\/j.heliyon.2024.e40404_bib29","unstructured":"RCSB Protein Data Bank, https:\/\/www.rcsb.org\/, as accessed in August 2022."},{"key":"10.1016\/j.heliyon.2024.e40404_bib30","series-title":"Schrodinger Suite","year":"2019"},{"key":"10.1016\/j.heliyon.2024.e40404_bib31","doi-asserted-by":"crossref","first-page":"11225","DOI":"10.1021\/ja9621760","article-title":"Development and testing of the OPLS ALL-ATOM force field on conformational energetics and properties of organic liquids","volume":"118","author":"Jorgensen","year":"1996","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.heliyon.2024.e40404_bib32","doi-asserted-by":"crossref","first-page":"7304","DOI":"10.1080\/07391102.2023.2239923","article-title":"Employing comparative QSAR techniques for the recognition of dibenzofuran and dibenzothiophene derivatives toward MMP-12 inhibition","volume":"42","author":"Tamang","year":"2024","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.heliyon.2024.e40404_bib33","doi-asserted-by":"crossref","first-page":"7888","DOI":"10.1002\/slct.201701330","article-title":"Understanding chemico-biological interactions of glutamate MMP-2 inhibitors through rigorous alignment-dependent 3D-QSAR analyses","volume":"2","author":"Adhikari","year":"2017","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.heliyon.2024.e40404_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2021.132041","article-title":"Ligand-based quantitative structural assessments of SARS-CoV-2 3CLpro inhibitors: an analysis in light of structure-based multi-molecular modeling evidences","volume":"1251","author":"Adhikari","year":"2022","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.heliyon.2024.e40404_bib36","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S1093-3263(01)00123-1","article-title":"Beware of q2","volume":"20","author":"Golbraikh","year":"2002","journal-title":"J. Mol. Graph. Model."},{"key":"10.1016\/j.heliyon.2024.e40404_bib37","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1002\/jcc.23231","article-title":"Some case studies on application of \"r(m)2\" metrics for judging quality of quantitative structure-activity relationship predictions: emphasis on scaling of response data","volume":"34","author":"Roy","year":"2013","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.heliyon.2024.e40404_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/1062936X.2021.2013317","article-title":"Applying comparative molecular modelling techniques on diverse hydroxamate-based HDAC2 inhibitors: an attempt to identify promising structural features for potent HDAC2 inhibition","volume":"33","author":"Yadav","year":"2022","journal-title":"SAR QSAR Environ. Res."},{"key":"10.1016\/j.heliyon.2024.e40404_bib39","doi-asserted-by":"crossref","first-page":"6029","DOI":"10.1007\/s00044-013-0590-8","article-title":"Exploring structural requirements of aurone derivatives as antimalarials by validated DFT-based QSAR, HQSAR, and COMFA-COMSIA approach","volume":"22","author":"Adhikari","year":"2013","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.heliyon.2024.e40404_bib40","doi-asserted-by":"crossref","first-page":"5959","DOI":"10.1021\/ja00226a005","article-title":"Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins","volume":"110","author":"Cramer","year":"1988","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.heliyon.2024.e40404_bib41","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2174\/156802610790232260","article-title":"3D-QSAR in drug design--a review","volume":"10","author":"Verma","year":"2010","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.heliyon.2024.e40404_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1023\/A:1008047919606","article-title":"Comparative molecular similarity index analysis (CoMSIA) to study hydrogen-bonding properties and to score combinatorial libraries","volume":"13","author":"Klebe","year":"1999","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.heliyon.2024.e40404_bib43","series-title":"SYBYL-X 2.0 Software","year":"2012"},{"key":"10.1016\/j.heliyon.2024.e40404_bib44","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1002\/ardp.201500045","article-title":"Generated 3D-common feature hypotheses using the HipHop method for developing new topoisomerase I inhibitors","volume":"348","author":"Ataei","year":"2015","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.heliyon.2024.e40404_bib45","doi-asserted-by":"crossref","first-page":"635","DOI":"10.3109\/14756360903393817","article-title":"Common feature-based 3D-pharmacophore model generation and virtual screening: identification of potential PfDHFR inhibitors","volume":"25","author":"Adane","year":"2010","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.heliyon.2024.e40404_bib46","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.compbiolchem.2018.10.016","article-title":"Pharmacophore-based virtual screening for identification of potential selective inhibitors of human histone deacetylase 6","volume":"77","author":"Uba","year":"2018","journal-title":"Comput. Biol. Chem."},{"key":"10.1016\/j.heliyon.2024.e40404_bib47","unstructured":"http:\/\/dude.docking.org\/, as accessed in October 2022."},{"key":"10.1016\/j.heliyon.2024.e40404_bib48","doi-asserted-by":"crossref","first-page":"6582","DOI":"10.1021\/jm300687e","article-title":"Directory of useful decoys, enhanced (DUD-E): better ligands and decoys for better benchmarking","volume":"55","author":"Mysinger","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.heliyon.2024.e40404_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiolchem.2020.107322","article-title":"Geo-Measures: a PyMOL plugin for protein structure ensembles analysis","volume":"87","author":"Kagami","year":"2020","journal-title":"Comput. Biol. Chem."},{"key":"10.1016\/j.heliyon.2024.e40404_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiolchem.2024.108051","article-title":"An assessment of crucial structural contributors of HDAC6 inhibitors through fragment-based non-linear pattern recognition and molecular dynamics simulation approaches","volume":"110","author":"Banerjee","year":"2024","journal-title":"Comput. Biol. Chem."},{"key":"10.1016\/j.heliyon.2024.e40404_bib51","unstructured":"Groningen machine for chemical simulations; Software available at: https:\/\/www.gromacs.org\/.As accessed in October 2024."},{"key":"10.1016\/j.heliyon.2024.e40404_bib52","doi-asserted-by":"crossref","DOI":"10.1063\/5.0018516","article-title":"Heterogeneous parallelization and acceleration of molecular dynamics simulations in GROMACS","volume":"153","author":"P\u00e1ll","year":"2020","journal-title":"J. Chem. Phys."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024164353?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024164353?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T21:11:47Z","timestamp":1790543507000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024164353"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":51,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S2405844024164353"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e40404","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring the key structural attributes and chemico-biological interactions of pyridinone-based SARS-CoV-2 3CLpro inhibitors through validated structure-based drug design strategies","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e40404","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e40404"}}